Zantac Litigation Continuing to Move Forward Through Video Conferences
The Initial Conference and attorney leadership interviews for Zantac federal consolidated litigation will be held via videoconferencing, due to the COVID-19 outbreak.…
«
»
The Initial Conference and attorney leadership interviews for Zantac federal consolidated litigation will be held via videoconferencing, due to the COVID-19 outbreak.…
A Delaware health insurance company has filed a class action lawsuit against a number of generic metformin manufacturers due to the presence of NDMA; a known cancer-causing agent.…
A federal judge wants parties to conduct a two-stage census to get an accurate count of all currently filed and pending Zantac lawsuits in federal courts nationwide.…
The FDA has called for the recall of all remaining Zantac products, after determining levels of NDMA increase over time while the heartburn drug is in storage.…
A Zantac lawsuit claims the recalled heartburn drug causes a woman to develop both stomach and liver cancer.…
Zantac litigation will continue with an interim attorney leadership team due to delays caused by the coronavirus pandemic.…
A new review looks at a variety of weight loss drugs following the Belviq recall, saying most are safe, but must be used wisely and not as a cure-all for obesity.…
A Zantac lawsuit claims exposure to high levels of NDMA in the heartburn drug resulted in a prostate cancer diagnosis.…
Parties involved in Zantac litigation have proposed allowing direct filing of new cases to the MDL court, to prevent delays from having the cases transferred from federal courts nationwide.…
The initial status conference for Zantac NDMA lawsuits has been cancelled due to concerns over the coronavirus.…